May 24, 2021 08:00AM
May 14, 2020 02:13PM
May 14, 2020 02:13PM
May 11, 2020 08:12AM
May 11, 2020 08:00AM
May 11, 2020 08:00AM
May 6, 2020 09:15AM Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
May 6, 2020 09:15AM
Apr 28, 2020 07:30AM
Apr 28, 2020 07:30AM
Apr 16, 2020 02:07PM
Apr 16, 2020 02:07PM
Jan 21, 2020 09:16AM
Jan 21, 2020 09:15AM Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
Jan 21, 2020 09:15AM
Aug 14, 2019 05:11PM
Aug 14, 2019 05:11PM
Aug 13, 2019 09:15AM
Aug 13, 2019 09:15AM
Aug 8, 2019 02:16PM
Jul 31, 2019 09:00AM Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings
Jul 31, 2019 09:00AM
Jul 11, 2019 05:32PM
Jul 11, 2019 05:28PM
Jul 11, 2019 05:28PM
Jul 2, 2019 09:03AM
Jul 2, 2019 09:00AM
Jul 2, 2019 09:00AM Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
Jun 20, 2019 09:18AM
Jun 20, 2019 09:15AM
Jun 20, 2019 09:15AM
May 30, 2019 07:00AM
May 30, 2019 07:00AM
May 14, 2019 07:57PM
May 14, 2019 07:57PM Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
May 7, 2019 09:19AM
May 7, 2019 09:15AM
May 7, 2019 09:15AM
Mar 29, 2019 09:00AM
Mar 5, 2019 08:35AM
Mar 5, 2019 08:30AM
Mar 5, 2019 08:30AM Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Feb 28, 2019 08:30AM
Feb 28, 2019 08:30AM
Feb 12, 2019 08:30AM
Feb 12, 2019 08:30AM
Jan 23, 2019 08:30AM
Jan 23, 2019 08:30AM
Dec 4, 2018 08:36AM Ritter Pharma (RTTR) Reports Over 50% Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Dec 4, 2018 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All